Where Consciousness Meets Capital.
CarMa Institute is a boutique investor relations and capital advisory firm focused on high-growth companies at the frontier of healthtech, biotech, neuroplastogen, and wellness innovation.
We work with founders and leadership teams to build capital narratives that convert conviction into capital—backed by data, differentiated positioning, and global investor alignment.
From pitch architecture and narrative design to investor targeting and due diligence prep, we help mission-driven ventures close aligned raises with precision and velocity. With deep roots in medicine, venture building, and capital markets, our team brings together the strategic insight of Global Markets with the integrity of purpose-led entrepreneurship.
Our network includes UHNWIs, family offices, and private investors across MENA and APAC regions.
Sectors we serve:
Pharmatech, Biotech & CDMO
Neuroplastogen therapeutics
Medical universities & academic research institutions
Healthtech & digital health
Human performance & wellness innovation
Company Details
- Founded
- -
- Address
- Engagement
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Keywords
- Investor Relations, Capital Raising Strategy, Healthtech & Digital Health, Pharmatech, Neuroplastogen, New Therapeutic Molecules, CDMA, Biotech, Fundraising Readiness, Global Investor Access, Family Office Engagement, Narrative Design, Venture Advisory, Conscious Capital, Medical Strategy, Impact Ventures, Medicine.
Carma Institute Questions
Carma Institute's LinkedIn profile is https://www.linkedin.com/company/carma-institute
Carma Institute's industry is
Venture Capital and Private Equity Principals
Carma Institute's top competitors are
South Point,
Hea Ventures,
Nahda Fund,
Benya Ventures,
Imkon Ventures,
Carma,
Dbth Capital,
Spheric Strategies Fzc,
Khorasani Ventures,
Maroon Ventures.
Carma Institute's categories are Venture Capital and Private Equity Principals
Carma Institute's founding year is 2025
